Aterian, Inc.

NasdaqCM:ATER Lagerbericht

Marktkapitalisierung: US$17.1m

Aterian Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Aterian wird ein Gewinn- und Umsatzwachstum von 18.1% bzw. 1.1% pro Jahr prognostiziert, während der Gewinn pro Aktie um 23.2% pro Jahr wachsen soll.

Wichtige Informationen

18.1%

Wachstumsrate der Gewinne

23.2%

EPS-Wachstumsrate

Consumer Durables Gewinnwachstum9.0%
Wachstumsrate der Einnahmen1.1%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert12 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Recent updates

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Is Aterian (NASDAQ:ATER) A Risky Investment?

Oct 15
Is Aterian (NASDAQ:ATER) A Risky Investment?

Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aug 11
Aterian, Inc. (NASDAQ:ATER) Just Reported, And Analysts Assigned A US$9.67 Price Target

Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Jul 17
Aterian, Inc. (NASDAQ:ATER) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

May 14
Aterian, Inc.'s (NASDAQ:ATER) Share Price Boosted 30% But Its Business Prospects Need A Lift Too

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

May 09
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Aterian, Inc. (NASDAQ:ATER) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Oct 12
Does Aterian (NASDAQ:ATER) Have A Healthy Balance Sheet?

Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Aug 14
Things Look Grim For Aterian, Inc. (NASDAQ:ATER) After Today's Downgrade

Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

May 13
Is Aterian (NASDAQ:ATER) Weighed On By Its Debt Load?

Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Mar 12
Analysts Have Been Trimming Their Aterian, Inc. (NASDAQ:ATER) Price Target After Its Latest Report

Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Jan 18
Are Investors Undervaluing Aterian, Inc. (NASDAQ:ATER) By 46%?

Aterian gains on guiding Q3 net revenue range above the consensus; resumes M&A strategy

Sep 30

Aterian's Silver Lining

Aug 22

Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aug 17
Estimating The Fair Value Of Aterian, Inc. (NASDAQ:ATER)

Aterian GAAP EPS of -$0.26 misses by $0.08, revenue of $58.27M misses by $1.34M

Aug 08

Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Jul 28
Is Aterian (NASDAQ:ATER) Using Too Much Debt?

Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Jul 08
Should You Think About Buying Aterian, Inc. (NASDAQ:ATER) Now?

Gewinn- und Umsatzwachstumsprognosen

NasdaqCM:ATER - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026108-12N/AN/A1
12/31/2025103-13-4-43
12/31/202498-14-1-13
9/30/2024107-18-3-3N/A
6/30/2024121-23-2-2N/A
3/31/2024128-54-6-6N/A
12/31/2023143-75-14-13N/A
9/30/2023165-87-7-6N/A
6/30/2023191-198-4-4N/A
3/31/2023214-179-12-12N/A
12/31/2022221-196-18-17N/A
9/30/2022230-183-21-21N/A
6/30/2022231-176-31-31N/A
3/31/2022241-196-47-47N/A
12/31/2021248-236-42-42N/A
9/30/2021226-274-42-42N/A
6/30/2021217-164-18-18N/A
3/31/2021208-1311515N/A
12/31/2020186-6366N/A
9/30/2020170-37-5-4N/A
6/30/2020152-51-18-18N/A
3/31/2020122-65-30-30N/A
12/31/2019114-59-25-25N/A
9/30/2019109-49-24-24N/A
6/30/201993-39-29-29N/A
3/31/201977-31-33-33N/A
12/31/201873-32-30-30N/A
12/31/201736-23N/A-29N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ATER wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: ATER wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: ATER wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: ATERDie Einnahmen des Unternehmens (1.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: ATERDie Einnahmen des Unternehmens (1.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ATER in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y